Aquestive Therapeutics
AQST
AQST
45 hedge funds and large institutions have $10.8M invested in Aquestive Therapeutics in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
-6
Holders Change %
-11.76%
% of All Funds
0.76%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
5
Increased
11
Reduced
15
Closed
11
Calls
$33K
Puts
$9K
Net Calls
+$24K
Net Calls Change
-$128K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$763K |
| 2 |
Millennium Management
New York
|
+$543K |
| 3 |
CAC
Cowen and Company
New York
|
+$80K |
| 4 |
VF
Virtu Financial
New York
|
+$61.2K |
| 5 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$39K |
Top Sellers
| 1 |
GL
Graypoint LLC
Albany,
New York
|
-$1.08M |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
-$340K |
| 3 |
PP
PDT Partners
New York
|
-$265K |
| 4 |
Man Group
London,
United Kingdom
|
-$235K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$166K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$4K | -1,600 | Closed |
|